{"title_page": "Alexandra Newton", "text_new": "{{BLP sources|date=April 2020}}\n\n{{short description|British-born, US-based Protein Kinase C expert}}\n\n{{Infobox scientist\n| name              = Prof. Alexandra Newton\n| birth_place       = [[Cape Town]], [[South Africa]]\n| home_town         = [[San Diego]], [[California]]\n| thesis_title      = 'Intermembrane Protein Transfer'\n| alma_mater        = Stanford University (PhD)\n| website           = http://newtonlab.ucsd.edu\n| awards            = Julius Axelrod Award in Pharmacology, ASPET (2019), Biophysics of Health and Disease [[Biophysical Society]] (2020)\n| image             = [[File:Prof. Alexandra Newton.jpg|thumb|Dr Alexandra Newton]]\n| fields            = {{Plainlist|\n* [[Cell Signaling]]\n* [[Protein kinase C]]\n* [[Protein Kinase]]\n* [[AKT1]]\n* [[Protein phosphatase]]\n* [[Diglcyeride]]\n* [[PHLPP]]}}\n\n| workplaces        = {{Plainlist|\n* [[University of California, San Diego]]\n* [[Indiana University]]\n* [[Stanford University]]\n* [[University of California, Berkeley]]\n* [[Simon Fraser University]]}}\n}}\n\n'''Professor Alexandra Newton''' is Distinguished Professor of [[Pharmacology]] at the [[University of California, San Diego]].<ref>{{Cite web|url=http://newtonlab.ucsd.edu/|title=PKC Signaling Laboratory  - University of California, San Diego|last=|first=|date=|website=|url-status=live|archive-url=|archive-date=|access-date=}}</ref> Newton runs a multidisciplinary [[Protein kinase C]] and [[Cell signaling]] biochemistry and cell biology research group in the School of Life Sciences,<ref>{{Cite web | url=https://hsi.ucsd.edu/|title = Health Sciences International \u2013 University of California, San Diego}}</ref> investigating molecular mechanisms of [[signal tranduction]] in the [[Phospholipase C]] (PLC) and [[Phosphoinositide 3-kinase]] (PI3 kinase, or PI3-K) signaling pathways.<ref>{{Cite web|url=http://newtonlab.ucsd.edu/|title=PKC Signaling Laboratory  - University of California, San Diego|last=|first=|date=|website=|url-status=live|archive-url=|archive-date=|access-date=}}</ref> She has been continuously funded by the US [[National Institutes of Health]] since 1998.\n\n== Early Life and Education ==\nNewton was born in [[Cape Town]], [[South Africa]], and was schooled in [[Vancouver]], [[Athens]], and [[Aix-en-Provence]].  She graduated in 1980 from the [[Simon Fraser University]] in Canada, where she was awarded a 1st-class honours degree in [[Biochemistry]] and [[French Literature]] <ref>{{Cite web | url=https://www.sfu.ca/science/alumni/inspiring-alumni/profiles/alexandra-newton.html|title = Inspiring Alumna, Simon Fraser University}}</ref>. She received her PhD in Chemistry in 1986 from [[Stanford University]], working with Wray H. Huestis <ref>{{Cite web|url=https://chemistry.stanford.edu/people/wray-huestis|title= Professor Wray Huestis Laboratory  - University of California, Stanford}}</ref> on a thesis examining signaling membrane proteins.<ref>{{cite journal|vauthors=Newton AC, Cook SL, Huestis WH |year=1983|title=Transfer of band 3, the erythrocyte anion transporter, between phospholipid vesicles and cells.|journal=Biochemistry|volume=22|issue=26|pages=6110\u20136117|pmid=6661430|}}</ref><ref>{{cite journal|vauthors=Huestis WH, Newton AC |year=1986|title=Transfer of band 3, the erythrocyte anion transporter, between phospholipid vesicles and cells.|journal=Journal of Biological Chemistry|volume=261|issue=34|pages=16274\u201316278|pmid=3782118|}}</ref>\n\n== Career ==\nFollowing her PhD defense, Newton took up a postdoctoral research position at [[University of California, Berkeley]] in the laboratory of [[Daniel E. Koshland Jr.]] between 1986 and 1988, and subsequently began her own independent research laboratory in 1988, as [[Assistant Professor]] in Chemistry at [[Indiana University]], subsequently receiving tenure as [[Associate Professor]] in 1994. She moved to [[University of California, San Diego]] in 1995, first as [[Associate Professor]] in [[Pharmacology]] and then Professor of Biological Chemistry, from 2001\u20132017. Between 2002 and 2006, she was Vice-chair, then Chair, of the Biomedical Sciences Graduate Program before becoming the Director of the Molecular Pharmacology Track in the Biomedical Sciences Graduate Program at the [[University of California San Diego]]. She was conferred with the title of Distinguished Professor of Pharmacology in 2017.\nAs of 2020, she is president-elect for the [[International Union of Biochemistry and Molecular Biology]], having served, since 2016, as ASBMB representative to the IUBMB general assembly, and, since 2015, as a Member of the [[International Union of Biochemistry and Molecular Biology]] Executive Committee for Congresses and Conferences. <ref>{{Cite web | url=https://iubmb.org/|title = International Union of Biochemistry and Molecular Biology}}</ref> Newton has supervised, and graduated, more 25 PhD postgraduate students and trained 23 Postdoctoral Fellows.<ref>{{Cite web|url=http://newtonlab.ucsd.edu/|title=PhD awards|last=|first=|date=|website=|url-status=live|archive-url=|archive-date=|access-date=}}</ref>\n\n== Research == \n\nNewton has been a major driver in the [[PKC]] research field since the 1980s, working originally with [[Daniel E. Koshland Jr.]] <ref>{{cite journal|vauthors=Newton A, Koshland DE |year=1987|title=Protein Kinase C Autophosphorylates by an Intrapeptide Reaction.|journal=Journal of Biological Chemistry|volume=262|issue=21|pages=10185\u201310188|pmid=3611058}}</ref><ref>{{cite journal|vauthors=Newton A, Koshland DE |year=1989|title=High cooperativity, specificity, and multiplicity in the protein kinase C-lipd interaction.|journal=Journal of Biological Chemistry|volume=264|issue=25|pages=14909\u201314915|pmid= 2768246 }}</ref> \u00a0She helped define the multiple different mechanisms of [[PKC]] regulation by [[phosphorylation]] and with membrane [[phospholipids]] such as [[phosphatidylserine]] <ref>{{cite journal|vauthors=Orr JW, Keranen LM, Newton AC|year=1992|title=Reversible exposure of the pseudosubstrate domain of protein kinase C by phosphatidylserine and diacylglycerol.|journal=Journal of Biological Chemistry|volume=267|issue=22|pages=15263\u201315266|pmid=1639770}}</ref><ref>{{cite journal|vauthors=Orr JW, Newton AC|year=1992|title=Interaction of protein kinase C with phosphatidylserine. 1. Cooperativity in lipid binding.|journal=Biochemistry|volume=31|issue=19|pages=4661\u20134667|pmid=1581316}}</ref><ref>{{cite journal|vauthors=Orr JW, Newton AC|year=1992|title=Interaction of protein kinase C with phosphatidylserine. 2. Specificity and regulation.|journal=Biochemistry|volume=31|issue=19|pages=4667\u20134673|pmid=1581317}}</ref><ref>{{cite journal|vauthors=Orr JW, Newton A |year=1994|title=Requirement for negative charge on \"activation loop\" of protein kinase C.|journal=Journal of Biological Chemistry|volume=269|issue=44|pages=27715\u201327718|pmid=7961692}}</ref> She has also made important discoveries as to how the two [[PHLPP]] (PH domain and Leucine rich repeat Protein Phosphatases) regulate intracellular signaling.<ref>{{cite journal|vauthors=Baffi TR, Van AN, Zhao W, Mills GB, Newton AC |year=2019|title=Protein Kinase C Quality Control by Phosphatase PHLPP1 Unveils Loss-of-Function Mechanism in Cancer.|journal=Molecular Cell|volume=74|issue=2|pages=378\u2013392|pmid=30904392|doi=10.1007/10.1016/j.molcel.2019.02.018|}}</ref><ref>{{cite journal|vauthors=Grzechnik AT, Newton AC |year=2019|title=PHLPPing through history: a decade in the life of PHLPP phosphatases.|journal=Biochemical Society Transactions|volume=44|issue=6|pages=1675\u20131682|pmid=27913677|doi= 10.1042/BST20160170|}}</ref>\n\nAs of 2020, Professor Newton has published over 190 peer-reviewed research articles that have been cited more than 25,000 times<ref>{{Cite web|url=https://scholar.google.co.uk/citations?hl=en&user=isrem4IAAAAJ|title=Alexandra Newton Google Scholar \u2013 University of California, San Diego}}</ref>, been awarded 1 patent <ref>{{citation|title=Chimeric phosphorylation indicator: US Patent No. 8,669,074|year=2004|vauthors=Violin JD, Newton AC, Tsien RJ, Zhang J}}</ref> and co-edited two books on protein biochemistry and [[PKC]].<ref>{{cite journal|vauthors=Malacinski GM, Frielder D|year=1993|title=Chapter 4: Essentials of Molecular Biology: The physical structure of protein molecules|journal=Jones & Bartlett Publishers,Boston|pages=335|ISBN=978-0-8672-0137-6}}</ref><ref>{{cite journal|vauthors= Newton AC |year=2003|title=Methods in Molecular Biology 233: Protein Kinase C Protocols.|journal=Humana Press|pages=584|ISBN=978-1-59259-397-2}}</ref> \n\n== Editorials, research honours, scientific service and outreach ==\n\nNewton was a member of the Editorial Board of the [[Journal of Biological Chemistry]] between 1995-2000, an associate editor of Molecular Pharmacology (2000-2003)\nand since 1990, has been an expert reviewer for the [[NSF]] and [[Medical Research Council of Canada]]. She has been chair, or co-chair, for multiple committees of the [[American Society for Biochemistry and Molecular Biology]]\n\n== References ==\n{{reflist}}\n\n{{DEFAULTSORT:Flitsch, Sabine}}<br />\n[[Category:Living people]]\n[[Category:People from Wigan]]\n[[Category:University of California, San Diego faculty]]\n[[Category:Stanford University faculty]]\n[[Category:University of California, Berkeley faculty]]\n[[Category:Simon Fraser University faculty]]\n[[Category:Stanford University alumni]]\n[[Category:American pharmacologists]]\n[[Category:British pharmacologists]]\n", "text_old": "{{BLP sources|date=April 2020}}\n\n{{short description|British-born, US-based Protein Kinase C expert}}\n\n{{Infobox scientist\n| name              = Prof. Alexandra Newton\n| birth_place       = [[Cape Town]], [[South Africa]]\n| home_town         = [[San Diego]], [[California]]\n| thesis_title      = 'Intermembrane Protein Transfer'\n| alma_mater        = Stanford University (PhD)\n| website           = http://newtonlab.ucsd.edu\n| awards            = Julius Axelrod Award in Pharmacology, ASPET (2019), Biophysics of Health and Disease [[Biophysical Society]] (2020)\n| image             = [[File:Dr Alexandra Newton.jpg|thumb|Dr Alexandra Newton]]\n| fields            = {{Plainlist|\n* [[Cell Signaling]]\n* [[Protein kinase C]]\n* [[Protein Kinase]]\n* [[AKT1]]\n* [[Protein phosphatase]]\n* [[Diglcyeride]]\n* [[PHLPP]]}}\n\n| workplaces        = {{Plainlist|\n* [[University of California, San Diego]]\n* [[Indiana University]]\n* [[Stanford University]]\n* [[University of California, Berkeley]]\n* [[Simon Fraser University]]}}\n}}\n\n'''Professor Alexandra Newton''' is Distinguished Professor of [[Pharmacology]] at the [[University of California, San Diego]].<ref>{{Cite web|url=http://newtonlab.ucsd.edu/|title=PKC Signaling Laboratory  - University of California, San Diego|last=|first=|date=|website=|url-status=live|archive-url=|archive-date=|access-date=}}</ref> Newton runs a multidisciplinary [[Protein kinase C]] and [[Cell signaling]] biochemistry and cell biology research group in the School of Life Sciences,<ref>{{Cite web | url=https://hsi.ucsd.edu/|title = Health Sciences International \u2013 University of California, San Diego}}</ref> investigating molecular mechanisms of [[signal tranduction]] in the [[Phospholipase C]] (PLC) and [[Phosphoinositide 3-kinase]] (PI3 kinase, or PI3-K) signaling pathways.<ref>{{Cite web|url=http://newtonlab.ucsd.edu/|title=PKC Signaling Laboratory  - University of California, San Diego|last=|first=|date=|website=|url-status=live|archive-url=|archive-date=|access-date=}}</ref> She has been continuously funded by the US [[National Institutes of Health]] since 1998.\n\n== Early Life and Education ==\nNewton was born in [[Cape Town]], [[South Africa]], and was schooled in [[Vancouver]], [[Athens]], and [[Aix-en-Provence]].  She graduated in 1980 from the [[Simon Fraser University]] in Canada, where she was awarded a 1st-class honours degree in [[Biochemistry]] and [[French Literature]] <ref>{{Cite web | url=https://www.sfu.ca/science/alumni/inspiring-alumni/profiles/alexandra-newton.html|title = Inspiring Alumna, Simon Fraser University}}</ref>. She received her PhD in Chemistry in 1986 from [[Stanford University]], working with Wray H. Huestis <ref>{{Cite web|url=https://chemistry.stanford.edu/people/wray-huestis|title= Professor Wray Huestis Laboratory  - University of California, Stanford}}</ref> on a thesis examining signaling membrane proteins.<ref>{{cite journal|vauthors=Newton AC, Cook SL, Huestis WH |year=1983|title=Transfer of band 3, the erythrocyte anion transporter, between phospholipid vesicles and cells.|journal=Biochemistry|volume=22|issue=26|pages=6110\u20136117|pmid=6661430|}}</ref><ref>{{cite journal|vauthors=Huestis WH, Newton AC |year=1986|title=Transfer of band 3, the erythrocyte anion transporter, between phospholipid vesicles and cells.|journal=Journal of Biological Chemistry|volume=261|issue=34|pages=16274\u201316278|pmid=3782118|}}</ref>\n\n== Career ==\nFollowing her PhD defense, Newton took up a postdoctoral research position at [[University of California, Berkeley]] in the laboratory of [[Daniel E. Koshland Jr.]] between 1986 and 1988, and subsequently began her own independent research laboratory in 1988, as [[Assistant Professor]] in Chemistry at [[Indiana University]], subsequently receiving tenure as [[Associate Professor]] in 1994. She moved to [[University of California, San Diego]] in 1995, first as [[Associate Professor]] in [[Pharmacology]] and then Professor of Biological Chemistry, from 2001\u20132017. Between 2002 and 2006, she was Vice-chair, then Chair, of the Biomedical Sciences Graduate Program before becoming the Director of the Molecular Pharmacology Track in the Biomedical Sciences Graduate Program at the [[University of California San Diego]]. She was conferred with the title of Distinguished Professor of Pharmacology in 2017.\nAs of 2020, she is president-elect for the [[International Union of Biochemistry and Molecular Biology]], having served, since 2016, as ASBMB representative to the IUBMB general assembly, and, since 2015, as a Member of the [[International Union of Biochemistry and Molecular Biology]] Executive Committee for Congresses and Conferences. <ref>{{Cite web | url=https://iubmb.org/|title = International Union of Biochemistry and Molecular Biology}}</ref> Newton has supervised, and graduated, more 25 PhD postgraduate students and trained 23 Postdoctoral Fellows.<ref>{{Cite web|url=http://newtonlab.ucsd.edu/|title=PhD awards|last=|first=|date=|website=|url-status=live|archive-url=|archive-date=|access-date=}}</ref>\n\n== Research == \n\nNewton has been a major driver in the [[PKC]] research field since the 1980s, working originally with [[Daniel E. Koshland Jr.]] <ref>{{cite journal|vauthors=Newton A, Koshland DE |year=1987|title=Protein Kinase C Autophosphorylates by an Intrapeptide Reaction.|journal=Journal of Biological Chemistry|volume=262|issue=21|pages=10185\u201310188|pmid=3611058}}</ref><ref>{{cite journal|vauthors=Newton A, Koshland DE |year=1989|title=High cooperativity, specificity, and multiplicity in the protein kinase C-lipd interaction.|journal=Journal of Biological Chemistry|volume=264|issue=25|pages=14909\u201314915|pmid= 2768246 }}</ref> \u00a0She helped define the multiple different mechanisms of [[PKC]] regulation by [[phosphorylation]] and with membrane [[phospholipids]] such as [[phosphatidylserine]] <ref>{{cite journal|vauthors=Orr JW, Keranen LM, Newton AC|year=1992|title=Reversible exposure of the pseudosubstrate domain of protein kinase C by phosphatidylserine and diacylglycerol.|journal=Journal of Biological Chemistry|volume=267|issue=22|pages=15263\u201315266|pmid=1639770}}</ref><ref>{{cite journal|vauthors=Orr JW, Newton AC|year=1992|title=Interaction of protein kinase C with phosphatidylserine. 1. Cooperativity in lipid binding.|journal=Biochemistry|volume=31|issue=19|pages=4661\u20134667|pmid=1581316}}</ref><ref>{{cite journal|vauthors=Orr JW, Newton AC|year=1992|title=Interaction of protein kinase C with phosphatidylserine. 2. Specificity and regulation.|journal=Biochemistry|volume=31|issue=19|pages=4667\u20134673|pmid=1581317}}</ref><ref>{{cite journal|vauthors=Orr JW, Newton A |year=1994|title=Requirement for negative charge on \"activation loop\" of protein kinase C.|journal=Journal of Biological Chemistry|volume=269|issue=44|pages=27715\u201327718|pmid=7961692}}</ref> She has also made important discoveries as to how the two [[PHLPP]] (PH domain and Leucine rich repeat Protein Phosphatases) regulate intracellular signaling.<ref>{{cite journal|vauthors=Baffi TR, Van AN, Zhao W, Mills GB, Newton AC |year=2019|title=Protein Kinase C Quality Control by Phosphatase PHLPP1 Unveils Loss-of-Function Mechanism in Cancer.|journal=Molecular Cell|volume=74|issue=2|pages=378\u2013392|pmid=30904392|doi=10.1007/10.1016/j.molcel.2019.02.018|}}</ref><ref>{{cite journal|vauthors=Grzechnik AT, Newton AC |year=2019|title=PHLPPing through history: a decade in the life of PHLPP phosphatases.|journal=Biochemical Society Transactions|volume=44|issue=6|pages=1675\u20131682|pmid=27913677|doi= 10.1042/BST20160170|}}</ref>\n\nAs of 2020, Professor Newton has published over 190 peer-reviewed research articles that have been cited more than 25,000 times<ref>{{Cite web|url=https://scholar.google.co.uk/citations?hl=en&user=isrem4IAAAAJ|title=Alexandra Newton Google Scholar \u2013 University of California, San Diego}}</ref>, been awarded 1 patent <ref>{{citation|title=Chimeric phosphorylation indicator: US Patent No. 8,669,074|year=2004|vauthors=Violin JD, Newton AC, Tsien RJ, Zhang J}}</ref> and co-edited two books on protein biochemistry and [[PKC]].<ref>{{cite journal|vauthors=Malacinski GM, Frielder D|year=1993|title=Chapter 4: Essentials of Molecular Biology: The physical structure of protein molecules|journal=Jones & Bartlett Publishers,Boston|pages=335|ISBN=978-0-8672-0137-6}}</ref><ref>{{cite journal|vauthors= Newton AC |year=2003|title=Methods in Molecular Biology 233: Protein Kinase C Protocols.|journal=Humana Press|pages=584|ISBN=978-1-59259-397-2}}</ref> \n\n== Editorials, research honours, scientific service and outreach ==\n\nNewton was a member of the Editorial Board of the [[Journal of Biological Chemistry]] between 1995-2000, an associate editor of Molecular Pharmacology (2000-2003)\nand since 1990, has been an expert reviewer for the [[NSF]] and [[Medical Research Council of Canada]]. She has been chair, or co-chair, for multiple committees of the [[American Society for Biochemistry and Molecular Biology]]\n\n== References ==\n{{reflist}}\n\n{{DEFAULTSORT:Flitsch, Sabine}}<br />\n[[Category:Living people]]\n[[Category:People from Wigan]]\n[[Category:University of California, San Diego faculty]]\n[[Category:Stanford University faculty]]\n[[Category:University of California, Berkeley faculty]]\n[[Category:Simon Fraser University faculty]]\n[[Category:Stanford University alumni]]\n[[Category:American pharmacologists]]\n[[Category:British pharmacologists]]\n", "name_user": "Pseudoenzyme", "label": "safe", "comment": "", "url_page": "//en.wikipedia.org/wiki/Alexandra_Newton"}
